ABSI
Absci Corp
NASDAQ · Biotechnology
$2.70
+0.17 (+6.52%)
Open$2.62
Previous Close$2.53
Day High$2.73
Day Low$2.53
52W High$6.33
52W Low$2.01
Volume—
Avg Volume3.51M
Market Cap405.25M
P/E Ratio—
EPS$-0.90
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+773.8% upside
Current
$2.70
$2.70
Target
$23.55
$23.55
$16.79
$23.55 avg
$35.63
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 6.18M | 6.29M | 59.64M |
| Net Income | -140,642,494 | -128,832,818 | -8,952,069 |
| Profit Margin | -2,274.1% | -2,160.4% | -15.0% |
| EBITDA | -121,515,235 | -117,495,647 | -13,022,432 |
| Free Cash Flow | — | — | -9,238,978 |
| Rev Growth | -1.8% | -1.8% | +20.4% |
| Debt/Equity | 0.02 | 0.02 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |